Gerald L. Hogue is Director of POINT Biopharma Global Inc.. Currently has a direct ownership of 0 shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Dec 26, 2023, when has been sold 21,596 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

GERALD L. HOGUE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
21,596 Reduced 100.0%
0 Common Stock
Mar 21 2023
BUY
Exercise of conversion of derivative security
$125,013 $6.97 p/Share
17,936 Added 45.37%
21,596 Common Stock
Nov 25 2022
BUY
Open market or private purchase
$24,961 $6.82 p/Share
3,660 Added 50.0%
3,660 Common Stock
GLH

Gerald L. Hogue

Director
Indianapolis, IN

Track Institutional and Insider Activities on PNT

Follow POINT Biopharma Global Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PNT shares.

Notify only if

Insider Trading

Get notified when an Point Biopharma Global Inc. insider buys or sells PNT shares.

Notify only if

News

Receive news related to POINT Biopharma Global Inc.

Track Activities on PNT